Beck Hopelessness Scale (BHS): how to read the result and why a score ≥9 is a clinical flag

9 min read

May 13, 2026

For Specialists

Beck, Steer, Kovacs & Garrison, Am J Psychiatry, 1985; n=207, 5–10-year prospective follow-up

91%

of hospitalized patients with suicidal ideation who later died by suicide had a baseline BHS score ≥ 10. Hopelessness as a cognitive construct predicted death by suicide more strongly than current ideation or depression severity — but the number needs context.

BHS as a risk indicator: what the data say

Beck 1985 (inpatients, cutoff ≥10)

91%

Beck 1990 (outpatients, cutoff ≥9)

94%

McMillan 2007 meta (sens, cutoff ≥9)

0,80

McMillan 2007 meta (spec, cutoff ≥9)

0,42

What BHS measures and why it matters

Aaron Beck (1974) developed BHS as a measure of stable negative expectations about the future — the "cognitive triad" he considered central not only to depression but to suicidal behavior. Beck's hypothesis: people who die by suicide do not usually "decide" in a moment of acute emotion — they have been convinced for a long time that improvement is impossible. That conviction of hopelessness is what BHS measures.

A key distinction: "hopelessness" in BHS sense is not mood and not current suicidal ideation. It is a cognitive structure of orientation toward the future — over 5–10 years, not "now". In this sense BHS fundamentally complements C-SSRS (Columbia Suicide Severity Rating Scale), which measures current ideation and behavior. The two scales cover two different risk horizons: BHS — chronic; C-SSRS — acute.

Key fact

BHS measures not the wish to die, but the absence of belief that things can improve. Empirically, it is this cognitive structure that predicts long-term suicide mortality more strongly than current suicidal ideation or depression severity at the time of assessment.

Beck 1985: 91% — the founding evidence

BHS rests on two prospective studies from Beck's group. The first — Beck, Steer, Kovacs & Garrison (1985, *Am J Psychiatry*). 207 hospitalized patients with suicidal ideation took BHS at admission. Over 5–10 years of follow-up, 14 died by suicide. A BHS cut-off of ≥ 10 identified 91% of the eventual cases. In that sample, hopelessness predicted suicide death more strongly than depression severity or current suicidal ideation taken separately.

The second key study — Beck, Brown, Berchick, Stewart & Steer (1990, *Am J Psychiatry*) — replicated the finding in 1,958 outpatients. There the threshold was BHS ≥ 9, sensitivity 94.2%, with relative suicide risk above threshold 11× the risk below. This — not the 1985 paper, as is sometimes mis-cited — is where the clinically used outpatient cut-off of ≥ 9 originated. The 1985 inpatient paper used ≥ 10; a one-point difference, but citation precision matters.

"Hopelessness was an even stronger predictor of suicidal intent than depression itself."— Beck A.T., Steer R.A., Kovacs M., Garrison B. American Journal of Psychiatry, 1985, 142(5):559–563

Scale structure: 20 true/false items

BHS contains 20 statements with a true/false response. The scale is binary: 0 or 1 per item. The sum, after reverse-scoring the positively-keyed items, yields a total of 0–20. Nine items are positively keyed (normative answer "true", describing hope), eleven are negatively keyed (normative answer "false", describing hopelessness). The balance reduces acquiescence bias — the tendency to agree regardless of content.

Item content spans three aspects of the future: affective ("expecting good vs darkness"), motivational ("worth trying or not"), cognitive ("my future is clear or vague"). Factor-analytic studies confirm these three factors as stable, although clinical practice usually relies on the single total score. Internal consistency is consistently high across international samples — Cronbach α between 0.82 and 0.93. Completion takes about 5 minutes.

20 items, binary true/false response
Total 0–20 after reverse-scoring 9 positively-keyed items
Completion time ~5 minutes
Cronbach α in the 0.82–0.93 range across international samples
Item text is licensed by Pearson Assessment — a license is required for clinical use

How to read the ≥9 threshold in practice

The standard four-band reading used in Soveria and in most clinical protocols:

0–3: minimal hopelessness — normal / non-clinical range
4–8: mild — monitor in the context of depressive symptoms
9–14: moderate — clinically significant, a red flag for long-term risk (the ≥9 threshold comes from Beck 1990, an outpatient sample of n=1,958)
15–20: severe — acute risk, especially with comorbid depression or recent suicidal ideation

Soveria · Measurement-Based Care

Start practicing MBC — from your first session

14 days free. Soveria integrates into your practice — no method change required.

Try for free

An important clinical caveat: BHS is a risk indicator, not sufficient grounds for a diagnosis or for any specific intervention. A score ≥ 9 says "look closer here"; what to do with that attention is a separate clinical question requiring C-SSRS, contextual assessment, attempt history, plan and means access. And conversely: a score below 9 does not mean "safe", especially in the presence of acute stressors or known high-risk factors.

BHS vs C-SSRS: hopelessness vs current ideation

These are two different constructs that complement, not duplicate, each other. C-SSRS (Columbia Suicide Severity Rating Scale, Posner et al. 2011) measures current suicidal ideation and behavior: was there a thought in the last month, a plan, means, intent, attempts. That is the "now" horizon — for assessing acute danger and making immediate decisions (hospitalization, means restriction, safety planning).

BHS measures the cognitive structure of attitude toward the future — is there belief that things can improve. That is the "next year — decade" horizon. High hopelessness without current suicidal ideation is a chronic risk factor invisible to C-SSRS. Conversely: current suicidal ideation alongside low BHS occurs in patients in an acute crisis phase with preserved hope — there the priority is acute intervention, not long-term hopelessness monitoring.

The key clinical scenario where this matters: a patient with C-SSRS "no current ideation" but BHS = 13. The current visible picture: "everything's fine". Structural risk: high. Without BHS this patient passes the safety screen and disappears from the preventive-intervention radar. The reverse scenario: C-SSRS shows a plan + access to means, BHS = 4 — that is an acute crisis requiring immediate action regardless of low hopelessness.

Limitations: what the meta-analysis shows

Here, honesty is needed. McMillan, Gilbody, Beresford & Neilly (2007, *Psychological Medicine*) meta-analyzed BHS predictive validity across 14 studies. At the ≥ 9 threshold, pooled sensitivity was 0.80, specificity 0.42. That means: BHS catches most future suicidal cases (low miss rate), but with many false positives — patients above the threshold who do not die by suicide.

This is not a "weakness" of BHS per se — it is the math of low base rates. Suicide in the general population is rare (a few cases per 100,000 person-years), and any screen at such a low baseline produces many false positives. So BHS is not a tool for "treat / don't treat" decisions based on a single score. It is a tool for "pay attention here". Brown, Beck, Steer & Grisham (2000) in a 20-year follow-up of 6,891 outpatients showed that BHS significantly predicts suicide in univariate analysis, but loses its unique contribution when SSI (Scale for Suicide Ideation) and diagnosis are added to a multivariate model. In other words, BHS is part of a battery, not a standalone prognosis.

Practical takeaway

BHS ≥ 9 does not mean "suicide tomorrow" and should not trigger alarm. It means a structural chronic risk factor is present and must be addressed in the treatment plan. Acute short-term danger is measured by C-SSRS; long-term risk by the combination of BHS + SSI + diagnosis + history + context. No single instrument works alone.

How to use BHS in practice

Bottom-line guidance — five typical workflows for private practice.

Screening at first presentation with depressive symptoms: PHQ-9 + BHS together. A BHS score ≥ 9 → add C-SSRS in the same session
Patient with a history of suicide attempts: BHS every 4–6 sessions for monitoring hopelessness as a structural factor
Inpatient / intensive program: BHS at admission as a risk baseline; repeat at discharge to evaluate change
Long-term outpatient therapy: BHS at sessions 12 and 24 to assess trajectory
Do not: use BHS as a standalone "suicide now" tool. C-SSRS does that. And do not make "treat / don't treat" decisions on a single BHS score — this is screening, not diagnosis

A brief note on Russian-language adaptation. The scale is used in Russian clinical practice and in several research studies — for example, a recent publication by Basova et al. (2025, *S.S. Korsakov Journal of Neurology and Psychiatry*) applies BHS in a Russian patient sample. However, a separate normative PubMed-indexed validation of BHS on a Russian-speaking sample — with published reliability coefficients and cut-off scores specific to the RF population — has not been found. For clinical practice this means: use a standardized translation and the international Beck 1990 cutoffs as a reference, always confirming the interpretation with clinical context.

BHS is available in Soveria for client assignment as 20 true/false items with automatic reverse-scoring of the 9 positively-keyed items and a four-band severity breakdown. Important platform note: BHS item text is licensed by Pearson Assessment — before clinical use, the instrument configuration must be updated with a licensed copy of the original statements. The scale structure, scoring, and interpretation on the platform match the published Beck 1974/1985/1990 specifications — but the specific item texts are not included in the public repository for copyright reasons.